| Literature DB >> 30662469 |
Binwu Hu1, Ruijun He1, Kaige Ma1, Zhe Wang1, Min Cui1, Hongzhi Hu1, Saroj Rai1,2, Baichuan Wang1, Zengwu Shao1.
Abstract
Intervertebral disc (IVD) degeneration is considered to be the primary reason for low back pain. Despite remarkable improvements in both pharmacological and surgical management of IVD degeneration (IVDD), therapeutic effects are still unsatisfactory. It is because of the fact that these therapies are mainly focused on alleviating the symptoms rather than treating the underlying cause or restoring the structure and biomechanical function of the IVD. Accumulating evidence has revealed that the endogenous stem/progenitor cells exist in the IVD, and these cells might be a promising cell source in the regeneration of degenerated IVD. However, the biological characteristics and potential application of IVD-derived stem/progenitor cells (IVDSCs) have yet to be investigated in detail. In this review, the authors aim to perform a review to systematically discuss (1) the isolation, surface markers, classification, and biological characteristics of IVDSCs; (2) the aging- and degeneration-related changes of IVDSCs and the influences of IVD microenvironment on IVDSCs; and (3) the potential for IVDSCs to promote regeneration of degenerated IVD. The authors believe that this review exclusively address the current understanding of IVDSCs and provide a novel approach for the IVD regeneration.Entities:
Year: 2018 PMID: 30662469 PMCID: PMC6312624 DOI: 10.1155/2018/7412304
Source DB: PubMed Journal: Stem Cells Int Impact factor: 5.443
Figure 1Schematic overview of the location of different kinds of IVDSCs. The stem cells located in IVD and the adjacent vertebras are indicated with dots. Elliptical broken line indicates the area of stem cell niche. The arrows indicate the possible migration pathways of SCNSCs. BMSC: bone marrow-derived stem cells; SCNSC: stem cell niche-derived stem cells; CESC: cartilage end plate-derived stem cells; NPSC: nucleus pulposus-derived stem cells; AFSC: annulus fibrosus-derived stem cells; CEPC: cartilage end plate cells. AFC: annulus fibrosus cells.
Surface markers of IVDSCs.
| Species | Cell type | Positive markers | Negative markers | References |
|---|---|---|---|---|
| Human | NPSC | CD73, CD90, and CD105 | CD34, CD45 | [ |
| Human | NPSC | CD73, CD90, and CD105 | CD34, CD45, and HLA-DR | [ |
| Rat | NPSC | CD44, CD90, and CD105 | CD34, CD45 | [ |
| Human | NPSC | CD29, CD44, and CD105 | CD14, CD34, CD45, and HLA-DR | [ |
| Human | NPSC | Tie2,GD2, Flt1, and CD271 | CD24 | [ |
| Mini pig | NPSC | CD29, CD90, and CD44 | — | [ |
| Rat | NPSC | CD73, CD90, and CD105 | CD34, CD45 | [ |
| Human | NPSC | CD29, CD44, CD73, CD90, and CD105 | CD29, CD44, CD73, CD90, and CD105 | [ |
| Human | NPSC | CD90, CD73, CD105, CD106, and CD166 | CD14, CD19, CD24, CD34, CD45, and HLA-DR, | [ |
| Human | NPSC | CD24, CD73, CD90, and CD105 | CD29, CD45 | [ |
| Rhesus macaque | NPSC | CD44, CD90, CD146, CD166, and HLA-DR | CD90, CD271 | [ |
| Human | AFSC, NPSC | CD49a, CD63, CD73, CD90, CD105, CD166, p75 NTR, and CD133/1 | CD34 | [ |
| Rhesus macaque | AFSC | CD44, CD90, CD146, CD166, and HLA-DR | CD29, CD106, and CD271 | [ |
| Human | AFSC | CD29, CD49e, CD51, CD73, CD90, CD105, CD166, CD184, nestin, and neuron-specific enolase | CD31, CD34, CD45, CD106, CD117, and CD133 | [ |
| Human | AFSC, NPSC, and CESC | CD73, CD90, and CD105 | CD19, CD34, CD45, and HLA-DR | [ |
| Human | CESC | CD73, CD90, and CD105 | CD14, CD19, CD34, CD45, and HLA-DR | [ |
| Human | CESC | CD73, CD90, CD105, and Stro-1 | CD14, CD19, CD34, CD45, and HLA-DR | [ |
| Human | CESC | CD44, CD73, CD90, CD105, CD133, CD166, and Stro-1 | CD14. CD19, CD34, CD45, and HLA-DR | [ |
| Rat | SCNSC | CD29, CD90, and CD44 | CD19, CD34, CD45, and CD11b | [ |
| Human | IVDSC | CD90, CD105, and Stro-1 | — | [ |